In-hospital death in acute coronary syndrome was related to admission glucose in men but not in women

Carregando...
Imagem de Miniatura
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Citação
CARDIOVASCULAR DIABETOLOGY, v.11, article ID 47, 9p, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Admission hyperglycaemia is associated with mortality in patients with acute coronary syndrome (ACS), but controversy exists whether hyperglycaemia uniformly affects both genders. We evaluated coronary risk factors, gender, hyperglycaemia and their effect on hospital mortality. Methods: 959 ACS patients (363 women and 596 men) were grouped based on glycaemia >= or < 200 mg/dL and gender: men with glucose < 200 mg/dL (menG-); women with glucose < 200 mg/dL (womenG-); men with glucose >= 200 mg/dL (menG+); and women with glucose >= 200 mg/dL (womenG+). A logistic regression analysis compared the relation between gender and glycaemia groups and death, adjusted for coronary risk factors and laboratory data. Results group: menG- had lower mortality than menG+ (OR = 0.172, IC95% 0.062-0.478), and womenG+ (OR = 0.275, IC95% 0.090-0.841); womenG- mortality was lower than menG+ (OR = 0.230, IC95% 0.074-0.717). No difference was found between menG+ vs womenG+ (p = 0.461), or womenG- vs womenG+ (p = 0.110). Age (OR = 1.067, IC95% 1.031-1.104), EF (OR = 0.942, IC95% 0.915-0.968), and serum creatinine (OR = 1.329, IC95% 1.128-1.566) were other independent factors related to in-hospital death. Conclusions: Death was greater in hyperglycemic men compared to lower blood glucose men and women groups, but there was no differences between women groups in respect to glycaemia after adjustment for coronary risk factors.
Palavras-chave
Myocardial infarction, Hyperglycaemia, Sex, Glycaemia, In-hospital prognosis
Referências
  1. Alpert JS, 2000, J AM COLL CARDIOL, V36, P959
  2. Barsheshet A, 2006, ARCH INTERN MED, V166, P1613, DOI 10.1001/archinte.166.15.1613
  3. Beck JA, 2009, AM J CARDIOL, V104, P1607, DOI 10.1016/j.amjcard.2009.07.040
  4. Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9
  5. Ceriello A, 2008, DIABETES VASC DIS RE, V5, P260, DOI 10.3132/dvdr.2008.038
  6. Champney KP, 2009, HEART, V95, P895, DOI 10.1136/hrt.2008.155804
  7. Cid-Alvarez B, 2009, AM HEART J, V158, P989, DOI 10.1016/j.ahj.2009.10.004
  8. Cubbon RM, 2007, EUR J CARDIOV PREV R, V14, P666
  9. Deshpande R, 1997, AM J REPROD IMMUNOL, V38, P46
  10. Falciglia M, 2009, CRIT CARE MED, V37, P3001, DOI 10.1097/CCM.0b013e3181b083f7
  11. Feinberg MS, 2007, AM J CARDIOL, V99, P667, DOI 10.1016/j.amjcard.2006.10.023
  12. Hoebers LP, 2011, AM J CARDIOL 0923
  13. Jensen CJ, 2011, CLIN RES CARDIOL, V100, P649, DOI 10.1007/s00392-011-0290-7
  14. Jneid H, 2008, CIRCULATION, V118, P2803, DOI 10.1161/CIRCULATIONAHA.108.789800
  15. Kawano H, 1999, J AM COLL CARDIOL, V34, P146, DOI 10.1016/S0735-1097(99)00168-0
  16. Kitada S, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-75
  17. Lazzeri C, 2010, DIABETES VASC DIS RE, V7, P131, DOI 10.1177/1479164109353369
  18. Malmberg K, 1999, CIRCULATION, V99, P2626
  19. Mansur AD, 2010, CLINICS, V65, P1143, DOI 10.1590/S1807-59322010001100016
  20. MARFELLA R, 1995, AM J PHYSIOL-ENDOC M, V268, pE1167
  21. Mather AN, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-61
  22. MODAN B, 1975, JAMA-J AM MED ASSOC, V233, P266, DOI 10.1001/jama.233.3.266
  23. Oberholzer A, 2000, J TRAUMA, V48, P932, DOI 10.1097/00005373-200005000-00019
  24. OSWALD GA, 1984, LANCET, V1, P1264
  25. OSWALD GA, 1986, BRIT MED J, V293, P917
  26. Ramos RB, 2011, CLINICS, V66, P437, DOI 10.1590/S1807-59322011000300013
  27. Schroder J, 1998, ARCH SURG-CHICAGO, V133, P1200, DOI 10.1001/archsurg.133.11.1200
  28. Sinnaeve PR, 2009, ARCH INTERN MED, V169, P402, DOI 10.1001/archinternmed.2008.572
  29. Straumann E, 2005, AM HEART J, V150, P1000, DOI 10.1016/j.ahj.2005.01.033
  30. Su G, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-19
  31. Takada JY, 2012, SCI WORLD J, DOI 10.1100/2012/397915
  32. Timmer JR, 2005, J AM COLL CARDIOL, V45, P999, DOI 10.1016/j.jacc.2004.12.050
  33. Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401
  34. Vaccarino V, 2009, ARCH INTERN MED, V169, P1767, DOI 10.1001/archinternmed.2009.332
  35. Valente S, 2012, EUR J PREV CARDIOL, V19, P233, DOI 10.1177/1741826711400511
  36. Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416
  37. Yu HT, 2011, YONSEI MED J, V52, P562, DOI 10.3349/ymj.2011.52.4.562